International Circulation: So you don’t think it would interfere with any of the guidelines for the treatment of heart failure?

    《国际循环》：因此，您并不认为它将影响任何一个指南对心衰治疗的指导？

    Prof. Nissen：I don’t think so. The guidelines now in the United States say ACE first， followed by ARBs as a

secondarychoice since they are useful. We don’t have quite as much of a problem with cough as there is in China， but I

can see how here having more options would be a good thing. 

    Nissen教授：我认为如此。美国指南认为首选ACE，其次为ARBs，因为他们更有效。我们并没有中国那么多咳嗽的患者，但是提供一种新选择总是很好的。